RAAS blockade ‘boosts survival’ post-SAVR: study
Use of ACEIs and ARBs cut the risk of death following surgery for severe aortic stenosis, doctors say.
Prolonged use of RAAS inhibitors may lead to better survival after surgical aortic valve replacement in patients with severe aortic stenosis, a population-based study shows.
Swedish cardiologists report that older adults who underwent surgical aortic valve replacement (SAVR) had a 13% lower risk of major adverse cardiovascular events when prescribed ACEIs or ARBs compared to those without RAAS inhibitor treatment.
